These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 26016418)

  • 1. Angiogenesis Inhibitor, Endostar, Prevents Vasa Vasorum Neovascularization in a Swine Atherosclerosis Model.
    Xu X; Mao W; Chai Y; Dai J; Chen Q; Wang L; Zhuang Q; Pan Y; Chen M; Ni G; Huang Z
    J Atheroscler Thromb; 2015; 22(10):1100-12. PubMed ID: 26016418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention of vasa vasorum neovascularization attenuates early neointima formation in experimental hypercholesterolemia.
    Gössl M; Herrmann J; Tang H; Versari D; Galili O; Mannheim D; Rajkumar SV; Lerman LO; Lerman A
    Basic Res Cardiol; 2009 Nov; 104(6):695-706. PubMed ID: 19458984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic endothelin receptor antagonism prevents coronary vasa vasorum neovascularization in experimental hypercholesterolemia.
    Herrmann J; Best PJ; Ritman EL; Holmes DR; Lerman LO; Lerman A
    J Am Coll Cardiol; 2002 May; 39(9):1555-61. PubMed ID: 11985922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduction in Vasa Vasorum Angiogenesis by Lp-PLA2 Selective Inhibitor Through The HIF-1α and VEGF Expression Under Dyslipidemic Conditions in Atherosclerosis Pathogenesis.
    Heriansyah T; Nafisatuzzamrudah N; Aini FN; Ridwan M; Primardhika RF; Wijayanti M; Bekti RS; Wihastuti TA
    Cardiovasc Hematol Agents Med Chem; 2018; 16(2):114-119. PubMed ID: 30394217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of lipids and intraplaque hypoxia in the formation of neovascularization in atherosclerosis.
    Chistiakov DA; Melnichenko AA; Myasoedova VA; Grechko AV; Orekhov AN
    Ann Med; 2017 Dec; 49(8):661-677. PubMed ID: 28797175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coronary vasa vasorum neovascularization precedes epicardial endothelial dysfunction in experimental hypercholesterolemia.
    Herrmann J; Lerman LO; Rodriguez-Porcel M; Holmes DR; Richardson DM; Ritman EL; Lerman A
    Cardiovasc Res; 2001 Sep; 51(4):762-6. PubMed ID: 11530109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vasa vasorum in atherosclerosis and clinical significance.
    Xu J; Lu X; Shi GP
    Int J Mol Sci; 2015 May; 16(5):11574-608. PubMed ID: 26006236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced coronary vasa vasorum neovascularization in experimental hypercholesterolemia.
    Kwon HM; Sangiorgi G; Ritman EL; McKenna C; Holmes DR; Schwartz RS; Lerman A
    J Clin Invest; 1998 Apr; 101(8):1551-6. PubMed ID: 9541483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreasing angiogenesis vasa vasorum through Lp-PLA2 and H2O2 inhibition by PSP from Ganoderma lucidum in atherosclerosis: in vivo diabetes mellitus type 2.
    Wihastuti TA; Amiruddin R; Cesa FY; Alkaf AI; Setiawan M; Heriansyah T
    J Basic Clin Physiol Pharmacol; 2020 Feb; 30(6):. PubMed ID: 32031980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fibroblast growth factor-2 is required for vasa vasorum plexus stability in hypercholesterolemic mice.
    Mollmark JI; Park AJ; Kim J; Wang TZ; Katzenell S; Shipman SL; Zagorchev LG; Simons M; Mulligan-Kehoe MJ
    Arterioscler Thromb Vasc Biol; 2012 Nov; 32(11):2644-51. PubMed ID: 22982464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperglycaemia is associated with impaired vasa vasorum neovascularization and accelerated atherosclerosis in apolipoprotein-E deficient mice.
    Veerman KJ; Venegas-Pino DE; Shi Y; Khan MI; Gerstein HC; Werstuck GH
    Atherosclerosis; 2013 Apr; 227(2):250-8. PubMed ID: 23411040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vasa vasorum anti-angiogenesis through H₂O₂, HIF-1α, NF-κB, and iNOS inhibition by mangosteen pericarp ethanolic extract (Garcinia mangostana Linn) in hypercholesterol-diet-given Rattus norvegicus Wistar strain.
    Wihastuti TA; Sargowo D; Tjokroprawiro A; Permatasari N; Widodo MA; Soeharto S
    Vasc Health Risk Manag; 2014; 10():523-31. PubMed ID: 25187725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantification of plaque neovascularization using contrast ultrasound: a histologic validation.
    Moguillansky D; Leng X; Carson A; Lavery L; Schwartz A; Chen X; Villanueva FS
    Eur Heart J; 2011 Mar; 32(5):646-53. PubMed ID: 20581005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adventitial vasa vasorum in balloon-injured coronary arteries: visualization and quantitation by a microscopic three-dimensional computed tomography technique.
    Kwon HM; Sangiorgi G; Ritman EL; Lerman A; McKenna C; Virmani R; Edwards WD; Holmes DR; Schwartz RS
    J Am Coll Cardiol; 1998 Dec; 32(7):2072-9. PubMed ID: 9857895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ultrasound Microbubble Delivery Targeting Intraplaque Neovascularization Inhibits Atherosclerotic Plaque in an APOE-deficient Mouse Model.
    Yuan H; Hu H; Sun J; Shi M; Yu H; Li C; Sun YU; Yang Z; Hoffman RM
    In Vivo; 2018; 32(5):1025-1032. PubMed ID: 30150423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contrast-enhanced ultrasound for imaging vasa vasorum: comparison with histopathology in a swine model of atherosclerosis.
    Schinkel AF; Krueger CG; Tellez A; Granada JF; Reed JD; Hall A; Zang W; Owens C; Kaluza GL; Staub D; Coll B; Ten Cate FJ; Feinstein SB
    Eur J Echocardiogr; 2010 Sep; 11(8):659-64. PubMed ID: 20385655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The vasa vasorum in diseased and nondiseased arteries.
    Mulligan-Kehoe MJ
    Am J Physiol Heart Circ Physiol; 2010 Feb; 298(2):H295-305. PubMed ID: 19940078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vasa Vasorum Angiogenesis: Key Player in the Initiation and Progression of Atherosclerosis and Potential Target for the Treatment of Cardiovascular Disease.
    Sedding DG; Boyle EC; Demandt JAF; Sluimer JC; Dutzmann J; Haverich A; Bauersachs J
    Front Immunol; 2018; 9():706. PubMed ID: 29719532
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The antiangiogenic activity of rPAI-1(23) inhibits vasa vasorum and growth of atherosclerotic plaque.
    Drinane M; Mollmark J; Zagorchev L; Moodie K; Sun B; Hall A; Shipman S; Morganelli P; Simons M; Mulligan-Kehoe MJ
    Circ Res; 2009 Feb; 104(3):337-45. PubMed ID: 19122176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tongxinluo mitigates atherogenesis by regulating angiogenic factors and inhibiting vasa vasorum neovascularization in apolipoprotein E-deficient mice.
    Ma L; Ni M; Hao P; Lu H; Yang X; Xu X; Zhang C; Huang S; Zhao Y; Liu X; Zhang Y
    Oncotarget; 2016 Mar; 7(13):16194-204. PubMed ID: 26908443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.